Literature DB >> 23156091

Changes in central corneal thickness, intraocular pressure, and oxidation/antioxidation parameters at high altitude.

Sarper Karakucuk1, Metin Mujdeci, Gulden Baskol, Hatice Arda, Koray Gumus, Ayse Oner.   

Abstract

BACKGROUND: The authors aimed at investigating ophthalmological changes at high altitude and correlating this with blood oxidation/antioxidation parameters.
METHODS: There were 40 volunteers who participated in the study. Initial ophthalmological examinations were performed at 3543 ft (1080 m) and repeated on the following day after the participants climbed to an altitude of 9186 ft (2800 m) on Mt. Erciyes, Turkey. Venous blood samples were taken at both altitudes to evaluate total oxidative system (TOS) and antioxidative system (TAS) levels.
RESULTS: IOP-right eyes at 3543 ft (1080 m) was 13.23 +/- 0.43 mmHg and significantly increased to 14.45 +/- 0.56 mmHg at 9186 ft (2800 m). LOP-left eyes at 3543 ft (1080 m) was 13.50 +/- 0.44 mmHg and increased to 14.13 +/- 0.54 mmHg at 9186 ft (2800 m) (P = n.s.). Central corneal thickness (CCT) of the right eyes was 540.98 +/- 4.34 microm at 3543 ft (1080 m) and significantly increased to 549.73 +/- 4.59 microm at 9186 ft (2800 m). CCT of the left eyes was 542.13 +/- 29.01 microm at 3543 ft (1080 m) and significantly increased to 547.23 +/- 4.59 microm at 9186 ft (2800 m). Spherical equivalent refraction of right or left eyes did not show any significant changes. TOS at 3543 ft (1080 m) was 5.33 +/- 0.76 micromol H2O2 equiv/L and significantly increased to 7.55 +/- 0.82 micromol H2O2 equiv/L at 9186 ft (2800 m). TAS at 3543 ft (1080 m) was 2.45 +/- 0.12 micromol H2O2 equiv/L and decreased to 2.22 +/- 0.08 micromol H2O2 equiv/L (P = n.s.) at 9186 ft (2800 m). There was a positive correlation between TAS and LOP at 9186 ft (2800 m).
CONCLUSION: Increased CCT can be related to stromal edema caused by hypoxia's effect on corneal endothelial function. Although TOS increased at high altitude, TAS did not show any parallel increase. Since this was nonacclimatized climbing, the antioxidant system could not have reached sufficient levels to counterbalance the observed oxidant stress.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23156091     DOI: 10.3357/asem.3357.2012

Source DB:  PubMed          Journal:  Aviat Space Environ Med        ISSN: 0095-6562


  6 in total

1.  Effect of obstructive sleep apnea syndrome on corneal thickness.

Authors:  Handan Inonu Koseoglu; Asiye Kanbay; Huseyin Ortak; Remzi Karadağ; Osman Demir; Selim Demir; Alper Gunes; Sibel Doruk
Journal:  Int Ophthalmol       Date:  2015-08-21       Impact factor: 2.031

2.  Evaluation of Intraocular pressure, Corneal thickness, and Retinal nerve fiber layer thickness in patients with Obstructive Sleep Apnea Syndrome.

Authors:  Kuddusi Teberik; Mehmet Tahir Eski; Ege Gulec Balbay; Murat Kaya
Journal:  Pak J Med Sci       Date:  2018 Jul-Aug       Impact factor: 1.088

3.  Intraocular Pressure Changes of Healthy Lowlanders at Different Altitude Levels: A Systematic Review and Meta-Analysis.

Authors:  Yiquan Yang; Yuan Xie; Yunxiao Sun; Kai Cao; Shuning Li; Sujie Fan; Lu Huang; Shizheng Wu; Ningli Wang
Journal:  Front Physiol       Date:  2019-11-06       Impact factor: 4.566

4.  Intraocular pressure and axial length changes during altitude acclimatization from Beijing to Lhasa.

Authors:  Yuan Wu; Ci Ren Qiong Da; Jiang Liu; Xiaoming Yan
Journal:  PLoS One       Date:  2020-01-29       Impact factor: 3.240

5.  Longitudinal observation of intraocular pressure variations with acute altitude changes.

Authors:  Yuan Xie; Yun-Xiao Sun; Ying Han; Di-Ya Yang; Yi-Quan Yang; Kai Cao; Shu-Ning Li; Xue Li; Xin-Xin Lu; Shi-Zheng Wu; Ning-Li Wang
Journal:  World J Clin Cases       Date:  2019-10-26       Impact factor: 1.337

6.  Changes in corneal thickness in patients with high-altitude pulmonary edema after systemic oxygen therapy.

Authors:  Sagarika Patyal; Arun Kumar Yadav; Atul Kotwal
Journal:  Indian J Ophthalmol       Date:  2018-11       Impact factor: 1.848

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.